{
  "docId": "019de075-7539-774f-abd7-26734f481c17",
  "docSlug": "efb32a48c20b71d9dd70ea37e2f1bc4b",
  "documentTitle": "argenx SE | Investor Presentation Deck | 26 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 26,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a 3D-like coordinate system to show expansion vectors.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7539-774f-abd7-26734f481c17/9",
  "deckHref": "/decks/019de075-7539-774f-abd7-26734f481c17",
  "deckJsonHref": "/decks/019de075-7539-774f-abd7-26734f481c17.json",
  "deckAnchorHref": "/decks/019de075-7539-774f-abd7-26734f481c17#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.85,
        "x": 0.1,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Expansion vectors for Formulations, Indications, and Geographies",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25a079a6-2a3f-493b-a81d-e25b4a5b87cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.2,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Formulations: VYVGART, VYVGART Hytrulo, Pre-Filled Syringe, Future Presentations",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d2d5d68-92fd-473a-b255-e7e9208d3ee2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.3,
        "y": 0.2
      },
      "kind": "list",
      "text": "Indications: gMG, CIDP, ITP, Pemphigus, BP, Myositis, Future Indications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b46d2482-d142-458b-b583-6ef4720980d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.85
      },
      "kind": "list",
      "text": "Geographies: US, Japan, EMEA, UK, China, Future Geographies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd437f95-b132-4ac5-80c2-4e20deaaa605",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.05
      },
      "kind": "title",
      "text": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b825846c-516e-46c8-957c-b01e934dec6f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "74fdd241-a342-4d52-9d53-9c5a008d1de9",
      "evidence": "Formulations: VYVGART, VYVGART Hytrulo, Pre-Filled Syringe, Future Presentations",
      "confidence": 0.5
    },
    {
      "name": "Journey frame",
      "slug": "journey-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "2431273b-2649-46ae-a2b1-44cad808a364",
      "evidence": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "roadmap",
      "slug": null,
      "matchId": "9b41615e-a3d1-4673-b74e-843ddd619b69",
      "evidence": "Visual representation of strategic growth vectors over time/scale.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "11df2160-3e69-4fb0-a01d-c12161d32bad",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "What",
      "beatSlug": "golden-circle-what",
      "evidence": "Slides 6-10 describe VYVGART and its benefits for patients with Generalized Myasthenia Gravis.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5a9162d2-2912-4933-9e05-dd879960544e",
      "evidence": "The document emphasizes the complexity and burden of existing treatments.",
      "position": 0,
      "objective": "Highlighting the need for improved treatment options for autoimmunity patients",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}